In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence

Detalhes bibliográficos
Autor(a) principal: Figueira, T. N.
Data de Publicação: 2017
Outros Autores: Palermo, L. M., Veiga, A. S., Huey, D., Alabi, C. A., Santos, N. C., Welsch, J. C., Mathieu, C., Horvat, B., Niewiesk, S., Moscona, A., Castanho, Miguel A. R. B., Porottob, M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/32558
Resumo: © 2016 American Society for Microbiology. All Rights Reserved.
id RCAP_a2cc691d2cc56c6858f332b1f29524fb
oai_identifier_str oai:repositorio.ul.pt:10451/32558
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residenceViral fusion inhibitorSelf-assembling nanoparticlesLipid taggingMembrane insertion© 2016 American Society for Microbiology. All Rights Reserved.Measles virus (MV) infection is undergoing resurgence and remains one of the leading causes of death among young children worldwide despite the availability of an effective measles vaccine. MV infects its target cells by coordinated action of the MV hemagglutinin (H) and fusion (F) envelope glycoproteins; upon receptor engagement by H, the prefusion F undergoes a structural transition, extending and inserting into the target cell membrane and then refolding into a postfusion structure that fuses the viral and cell membranes. By interfering with this structural transition of F, peptides derived from the heptad repeat (HR) regions of F can inhibit MV infection at the entry stage. In previous work, we have generated potent MV fusion inhibitors by dimerizing the F-derived peptides and conjugating them to cholesterol. We have shown that prophylactic intranasal administration of our lead fusion inhibitor efficiently protects from MV infection in vivo. We show here that peptides tagged with lipophilic moieties self-assemble into nanoparticles until they reach the target cells, where they are integrated into cell membranes. The selfassembly feature enhances biodistribution and the half-life of the peptides, while integration into the target cell membrane increases fusion inhibitor potency. These factors together modulate in vivo efficacy. The results suggest a new framework for developing effective fusion inhibitory peptides.This work was supported by NIH grants NS091263 (NINDS) and AI119762 and AI109050 (NIAID) to M.P. and AI101333 and AI114736-01 (NIAID) to A.M., Fundação para a Ciência e Tecnologia-Ministério da Ciência, Tecnologia e Ensino Superior (FCT-MCTES, Portugal) projects VIH/SAU/0047/2011 to A.S.V. and PTDC/BBB-BQB/3494/2014 to N.C.S., and INSERM and the LABEX ECOFECT (ANR-11-LABX-0048) of Lyon University, within the program “Investissements d’Avenir” (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR), to B.H. T.N.F. and A.S.V. acknowledge FCT for Ph.D. fellowship SFRH/BD/52383/2013 and fellowship IF/00803/2012 under the FCT Investigator Programme, respectively.American Society for MicrobiologyRepositório da Universidade de LisboaFigueira, T. N.Palermo, L. M.Veiga, A. S.Huey, D.Alabi, C. A.Santos, N. C.Welsch, J. C.Mathieu, C.Horvat, B.Niewiesk, S.Moscona, A.Castanho, Miguel A. R. B.Porottob, M.2018-04-03T11:45:28Z20172017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/32558engJ Virol 91:e01554-160022-538X10.1128/ JVI.01554-16info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:26:55Zoai:repositorio.ul.pt:10451/32558Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:47:50.113789Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
title In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
spellingShingle In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
Figueira, T. N.
Viral fusion inhibitor
Self-assembling nanoparticles
Lipid tagging
Membrane insertion
title_short In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
title_full In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
title_fullStr In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
title_full_unstemmed In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
title_sort In vivo efficacy of measles virus fusion protein-derived peptides is modulated by the properties of self-assembly and membrane residence
author Figueira, T. N.
author_facet Figueira, T. N.
Palermo, L. M.
Veiga, A. S.
Huey, D.
Alabi, C. A.
Santos, N. C.
Welsch, J. C.
Mathieu, C.
Horvat, B.
Niewiesk, S.
Moscona, A.
Castanho, Miguel A. R. B.
Porottob, M.
author_role author
author2 Palermo, L. M.
Veiga, A. S.
Huey, D.
Alabi, C. A.
Santos, N. C.
Welsch, J. C.
Mathieu, C.
Horvat, B.
Niewiesk, S.
Moscona, A.
Castanho, Miguel A. R. B.
Porottob, M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Figueira, T. N.
Palermo, L. M.
Veiga, A. S.
Huey, D.
Alabi, C. A.
Santos, N. C.
Welsch, J. C.
Mathieu, C.
Horvat, B.
Niewiesk, S.
Moscona, A.
Castanho, Miguel A. R. B.
Porottob, M.
dc.subject.por.fl_str_mv Viral fusion inhibitor
Self-assembling nanoparticles
Lipid tagging
Membrane insertion
topic Viral fusion inhibitor
Self-assembling nanoparticles
Lipid tagging
Membrane insertion
description © 2016 American Society for Microbiology. All Rights Reserved.
publishDate 2017
dc.date.none.fl_str_mv 2017
2017-01-01T00:00:00Z
2018-04-03T11:45:28Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/32558
url http://hdl.handle.net/10451/32558
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv J Virol 91:e01554-16
0022-538X
10.1128/ JVI.01554-16
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv American Society for Microbiology
publisher.none.fl_str_mv American Society for Microbiology
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134405890932736